Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1992 Apr;67(4 Spec No):378–382. doi: 10.1136/adc.67.4_spec_no.378

Phosphatidylcholine composition of endotracheal tube aspirates of neonates and subsequent respiratory disease.

M R Ashton 1, A D Postle 1, M A Hall 1, S L Smith 1, F J Kelly 1, I C Normand 1
PMCID: PMC1590480  PMID: 1586174

Abstract

The phosphatidylcholine (PC) content of the initial endotracheal tube aspirate was measured in 105 infants intubated for resuscitation or for ventilation for respiratory distress syndrome, using high performance liquid chromatography and postcolumn fluorescence derivitization with diphenyl-1,3,5-hexatriene. Sixty eight had measurable PC. Of the infants who developed respiratory distress syndrome, with or without subsequent chronic lung disease, neither the percentage of dipalmitoylphosphatidylcholine (DPPC) nor the ratio of DPPC to palmitoyloleoylphosphatidylcholine (POPC), showed any correlation with gestational age. However, both parameters were significantly lower overall in this group than in the group of infants who did not develop respiratory distress syndrome. Infants with a ratio of DPPC:POPC less than 3.0 developed respiratory distress syndrome irrespective of gestational age, but there was considerable overlap between groups for values greater than this. The infants with respiratory distress syndrome who went on to develop chronic lung disease had the same initial PC profile as those with respiratory distress syndrome who did not develop chronic lung disease, but differed as a group by being lighter and more premature. The development of chronic lung disease was not associated with a particular initial PC composition. Other factors related to increasing prematurity must therefore be involved in rendering infants vulnerable to developing chronic lung disease.

Full text

PDF
378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autor A. P., Frank L., Roberts R. J. Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome. Pediatr Res. 1976 Mar;10(3):154–158. doi: 10.1203/00006450-197603000-00002. [DOI] [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Brumley G. W., Chernick V., Hodson W. A., Normand C., Fenner A., Avery M. E. Correlations of mechanical stability, morphology, pulmonary surfactant, and phospholipid content in the developing lamb lung. J Clin Invest. 1967 May;46(5):863–873. doi: 10.1172/JCI105586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caesar P. A., Wilson S. J., Normand C. S., Postle A. D. A comparison of the specificity of phosphatidylcholine synthesis by human fetal lung maintained in either organ or organotypic culture. Biochem J. 1988 Jul 15;253(2):451–457. doi: 10.1042/bj2530451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hallman M., Feldman B. H., Kirkpatrick E., Gluck L. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns. Pediatr Res. 1977 Jun;11(6):714–720. doi: 10.1203/00006450-197706000-00003. [DOI] [PubMed] [Google Scholar]
  6. Hallman M., Merritt T. A., Pohjavuori M., Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res. 1986 Dec;20(12):1228–1235. doi: 10.1203/00006450-198612000-00008. [DOI] [PubMed] [Google Scholar]
  7. Hunt A. N., Kelly F. J., Postle A. D. Developmental variation in whole human lung phosphatidylcholine molecular species: a comparison with guinea pig and rat. Early Hum Dev. 1991 Jun;25(3):157–171. doi: 10.1016/0378-3782(91)90112-g. [DOI] [PubMed] [Google Scholar]
  8. McElroy M., Postle T., Kelly F. Antioxidant activity in fetal and neonatal lung. Adv Exp Med Biol. 1990;264:449–454. doi: 10.1007/978-1-4684-5730-8_70. [DOI] [PubMed] [Google Scholar]
  9. Postle A. D. Method for the sensitive analysis of individual molecular species of phosphatidylcholine by high-performance liquid chromatography using post-column fluorescence detection. J Chromatogr. 1987 Apr 10;415(2):241–251. doi: 10.1016/s0378-4347(00)83216-8. [DOI] [PubMed] [Google Scholar]
  10. Schellhase D. E., Emrie P. A., Fisher J. H., Shannon J. M. Ontogeny of surfactant apoproteins in the rat. Pediatr Res. 1989 Sep;26(3):167–174. doi: 10.1203/00006450-198909000-00001. [DOI] [PubMed] [Google Scholar]
  11. Shenai J. P., Chytil F., Stahlman M. T. Vitamin A status of neonates with bronchopulmonary dysplasia. Pediatr Res. 1985 Feb;19(2):185–188. doi: 10.1203/00006450-198502000-00007. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES